Thyrocare Technologies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Thyrocare Technologies Ltd. on BSE

Load latest

Thyrocare Technologies Ltd.

23 Apr 2025

1003.90

-0.66%

Result

Thyrocare Technologies Ltd - 539871 - Financial Results For Quarter And Year Ended March 31, 2025 …

BSE India

please find attached herewith Audited Standalone and Consolidated Financial Results for Quarter and year ended March 31, 2025.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	191.75	169.93	157.74	12.8%	21.6%
Operating Profit Qtr	57.70	41.73	33.81	38.3%	70.7%
Net Profit Qtr	21.70	19.11	17.78	13.6%	22.0%
Earning Per Share Adjusted latest Qtr	4.09	3.61	3.36	13.3%	21.7%

* Consolidated data

Detailed Results

Thyrocare Technologies Ltd.

23 Apr 2025

1003.90

-0.66%

Board Meeting

Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting held on April 23, 2025

pdf

Thyrocare Technologies Ltd.

15 Apr 2025

1003.90

-0.66%

Company Update

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

We wish to intimate that a conference call for the analysts/investors is arranged by our management to discuss the Company's Audited financial results for the quarter and year ended March 31, 2025, on Wednesday April 23, 2025, at 6:00 pm. (IST). Details of which are attached herewith.

pdf

Thyrocare Technologies Ltd.

15 Apr 2025

1003.90

-0.66%

Board Meeting

Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Consideration And Approval Of Audited Standalone …

BSE India

Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, and to recommend the final dividend, if any, for the financial year 2024-25.

pdf

Thyrocare Technologies Ltd.

08 Apr 2025

1003.90

-0.66%

Company Update

Thyrocare Technologies Ltd - 539871 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find attached Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended March 31, 2025.

pdf

Thyrocare Technologies Ltd.

27 Mar 2025

1003.90

-0.66%

SAST

Thyrocare Technologies Ltd - 539871 - Closure of Trading Window

BSE India

Intimation for Closure of Trading Window.

pdf

Thyrocare Technologies Ltd.

03 Mar 2025

1003.90

-0.66%

Company Update

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Please find attached herewith Disclosure under Regulation 30 for Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited - Joint Venture.

pdf

Thyrocare Technologies Ltd.

03 Feb 2025

1003.90

-0.66%

Corp. Note

Thyrocare Technologies Ltd - 539871 - Integrated Filing (Financial)

BSE India

The Company has submitted the financial results along with Limited review report for quarter and nine months ended December 31, 2024. It is hereby submitted that due to an inadvertent error during the scanning process, a page containing Points No 4 to 6 of the Limited review report was inadvertently omitted. The corrected Limited Review report is attached herewith. There are no other changes to earlier intimation made on January 23, 2025.

pdf

Thyrocare Technologies Ltd.

03 Feb 2025

1003.90

-0.66%

Result

Thyrocare Technologies Ltd - 539871 - Updated Limited Review Report On The Consolidated Financial Results For …

BSE India

The Company has submitted the financials results along with Limited review Report for quarter and nine months ended December 31, 2024, It is hereby submitted that due to an inadvertent error during the scanning process, a page containing Points No 4 to 6 of the Limited Review Report was inadvertently omitted. The corrected Limited Review Report is attached herewith. There are no other changes to earlier intimation made on January 23, 2025.

pdf